These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 20738296)
1. Left-right determination factor is down-regulated in fibrotic renal tissue of human hydronephrosis. Yao Y; Zhang J; Ye DF; Tan DQ; Peng JP; Xie M; Fang L BJU Int; 2011 Mar; 107(6):1002-8. PubMed ID: 20738296 [TBL] [Abstract][Full Text] [Related]
2. Myofibroblasts in experimental hydronephrosis. Diamond JR; van Goor H; Ding G; Engelmyer E Am J Pathol; 1995 Jan; 146(1):121-9. PubMed ID: 7856721 [TBL] [Abstract][Full Text] [Related]
3. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466 [TBL] [Abstract][Full Text] [Related]
4. Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. Mariasegaram M; Tesch GH; Verhardt S; Hurst L; Lan HY; Nikolic-Paterson DJ Biochem Biophys Res Commun; 2010 Mar; 393(4):855-9. PubMed ID: 20171171 [TBL] [Abstract][Full Text] [Related]
5. BMP7 signaling in renal development and disease. Patel SR; Dressler GR Trends Mol Med; 2005 Nov; 11(11):512-8. PubMed ID: 16216558 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats. Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155 [TBL] [Abstract][Full Text] [Related]
7. Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis. Yang Y; Hou Y; Wang CL; Ji SJ Urology; 2006 Apr; 67(4):817-21; discussion 821-2. PubMed ID: 16618565 [TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta. Kaiser M; Haag J; Söder S; Bau B; Aigner T Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348 [TBL] [Abstract][Full Text] [Related]
9. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3. Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [TBL] [Abstract][Full Text] [Related]
11. Tissue factor expression in an animal model of hydronephrosis. Wendt T; Zhang YM; Bierhaus A; Kriegsmann J; Deng Y; Waldherr R; Teske T; Luther T; Fünfstück R; Nawroth PP Nephrol Dial Transplant; 1995 Oct; 10(10):1820-8. PubMed ID: 8592588 [TBL] [Abstract][Full Text] [Related]
12. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. Negri AL J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and Smad signalling in kidney diseases. Wang W; Koka V; Lan HY Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182 [TBL] [Abstract][Full Text] [Related]
14. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta. Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272 [TBL] [Abstract][Full Text] [Related]
15. [Expression of renal nuclear factor-kappaB, transforming growth factor-beta and fibronectin of rats exposed to lead]. Qiao YF; Jiang YS; Pang DZ Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Mar; 24(3):139-42. PubMed ID: 16600131 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. Morrissey J; Hruska K; Guo G; Wang S; Chen Q; Klahr S J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S14-21. PubMed ID: 11792757 [TBL] [Abstract][Full Text] [Related]
17. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Steenvoorden MM; Tolboom TC; van der Pluijm G; Löwik C; Visser CP; DeGroot J; Gittenberger-DeGroot AC; DeRuiter MC; Wisse BJ; Huizinga TW; Toes RE Arthritis Res Ther; 2006; 8(6):R165. PubMed ID: 17076892 [TBL] [Abstract][Full Text] [Related]
18. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Jain S; Bicknell GR; Nicholson ML Br J Surg; 2000 Nov; 87(11):1563-8. PubMed ID: 11091246 [TBL] [Abstract][Full Text] [Related]
20. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Chatziantoniou C; Dussaule JC Am J Physiol Renal Physiol; 2005 Aug; 289(2):F227-34. PubMed ID: 16006588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]